🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the efficacy and safety (including...
Status
Active Not Recruiting
Location
Research Site
Start Date
2018-10-31
Trial ID
NCT03732820
Treatments Being Tested
The purpose of this study is to find out whether talazoparib in combination...
Status
Recruiting
Location
City of Hope
Start Date
2026-05-04
Trial ID
NCT06844383
Treatments Being Tested
Primary Objectives: * To determine the maximum tolerated dose, and dose li...
Status
Completed
Location
Investigational Site Number 840001
Start Date
2012-03
Trial ID
NCT01511536
Treatments Being Tested
This is a Phase 1, open-label, multicenter study of continuous oral dosing ...
Status
Completed
Location
Research Site
Start Date
2016-06-17
Trial ID
NCT02740985
Treatments Being Tested
The purpose of this study is to compare the radiographic progression-free s...
Status
Active Not Recruiting
Location
Multiple Locations
Start Date
2014-11-26
Trial ID
NCT02257736
Treatments Being Tested
This is an open label study designed to examine the effects on concurrent a...
Status
Completed
Location
Chesapeake urology Research Associates
Start Date
2014-03
Trial ID
NCT02097303
Treatments Being Tested
The purpose of this study was to explore the safety and tolerability of enz...
Status
Completed
Location
Site US2492 MD Anderson Cancer Ctr
Start Date
2012-07-09
Trial ID
NCT01650194
Treatments Being Tested
The purpose of this study is to investigate the safety and efficacy of abir...
Status
Completed
Location
Multiple Locations
Start Date
2012-06
Trial ID
NCT01795703
Treatments Being Tested
ProBio is an international, outcome-adaptive, multi-arm, open-label, multip...
Status
Recruiting
Location
OLV Ziekenhuis Aalst
Start Date
2019-02-01
Trial ID
NCT03903835
The purpose of this international, phase 2, open-label, response rate study...
Status
Completed
Location
Arizona Oncology Associates
Start Date
2017-07-04
Trial ID
NCT03148795
Treatments Being Tested